Ascend Advanced Therapies | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

51,034 results for “Ascend Advanced Therapies”

Ascend Advanced Therapies Successfully Defends European Patent for EpyQ AAV Plasmid Technology

Ascend Advanced Therapies Achieves GMP Certification for AAV Gene Therapy Quality Control in Munich

Ascend Advanced Therapies Develops Proprietary Enhancers Boosting AAV Production Yields Up to 3-Fold

Certepetide Fails to Improve PFS in Metastatic Pancreatic Cancer: ASCEND Trial

FDA Expedited Designations: RMAT and Fast Track Gain Traction Over Breakthrough Therapy

Biocon and Zentiva Secure EU Approval for Liraglutide, a Generic Version of Victoza

Novel CLDN6-Targeted Therapies Show Promise in Advanced Solid Tumors

FDA Approvals Surge for Targeted Therapies in Advanced NSCLC

Supply Chain Evolution Critical for Pharmaceutical Industry's Shift to Advanced Therapies

Advanced Technologies Transform Quality Assurance in Emerging Cell and Gene Therapies

Page 1 of 2233